A Study in Healthy Subjects to Assess the Safety and Tolerability of a 120-hour Continuous Infusion of M6229
Clinical trial NCT07285603 · COMPLETED
Trial details
- NCT number
- NCT07285603
- Sponsor
- Matisse Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2025-06-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.